SavedAdd your journal

Journals / Tüberküloz ve Toraks / 2005 / Cilt: 53 - Sayı: 2

Treatment in diffuse interstitial lung diseases

Difüz interstisyel akciğer hastalıklarında tedavi

Oya KAYACAN
Pages
190–199
Publication Date
2022-11-04
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This paper deals with the treatment of idiopathic interstitial pneumonias and sarcoidosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diffuse interstitial lung diseases are parenchymal diseases of the lung with many various etiologies and most of which areidiopathic.
📊
Key Findings & Data:The main stays of the treatment are corticosteroids and immunosuppresants.
💡
Conclusion & Impact:This paper deals with the treatment of idiopathic interstitial pneumonias and sarcoidosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Diffuse interstitial lung diseases are parenchymal diseases of the lung with many various etiologies and most of which areidiopathic. The main stays of the treatment are corticosteroids and immunosuppresants. This paper deals with the treatment of idiopathic interstitial pneumonias and sarcoidosis.

Özet

Difüz interstisyel akciğer hastalıkları çeşitli nedenlere bağlı olarak gelişen, çoğu idiyopatik olup akciğer parankimini tutan hastalıklardır. Tedavilerinde başlıca kortikosteroidler ve immünsüpresifler kullanılır. Burada, idiyopatik interstisyel pnömonilerve sarkoidozun tedavisinden söz edilecektir.

🔖

Cite This Article

KAYACAN, O. (2022). Treatment in diffuse interstitial lung diseases. Tüberküloz ve Toraks, Cilt: 53 - Sayı: 2, 190–199. https://ajindex.com/articles/619172

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. King TE Jr. Idiopathic interstitial pneumonias.In:Schwarz Ml, King TE Jr (eds). Interstitial Lung Disease.3rd ed, London: BC Decker Inc, Hamilton, 2003: 701-86
  2. Freudenberger T, Ragu G. Idiopathic pulmonary fibrosis:an evolving approach to diagnosis and treatment Eur Respir Mon 2000; 14: 79-95
  3. Nagai S, Kitaichi M. Idiopathic interstitial pneumonias.In: Crapo JD, Glassroth J, Karlinsky JB, King TEJr (eds).Baum's Textbook of Pulmonary Diseases. 7th ed. Lippincott: Williams and Wilkins, 2004: 469-80
  4. Haslam PL, Turton CW, Lukoszeka A, et al. Bronchoalveolar lavage fluid cell counts in cryptogenic fibrosing alveolitis and their relation to therapy. Thorax 1980; 35:328-39
  5. ATS/ERS. Idiopathic pulmonary fibrosis: diagnosis and treatment (international consensus statement).Am J Respir Crit Care Med 2000; 161: 646-64
  6. Costabel U, King TE. International consensus statement on idiopathic pulmonary fibrosis. Eur Respir J 2001; 161:1172-8
  7. Douglas WW, Ryu JH, Schroeder DR. Idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2000; 161:1172-8
  8. Douglas WW, Ryu JH, Swense SJ, et al. Colchisine versus prednisone in the treatment of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 220-5
  9. Ziesche R, Hofbauer E, Wittmann K, et al. A preliminary study of long-term treatment with interferon gamma-1b and low dose prednisolone in patients with idiopathic pulmonary fibrosis. N Engl J Med 1999; 341: 1264-9
  10. Raghu G, Johnson WC, Lockhatr D, Mageto Y. Treatment of idiopathic pulmonary fibrosis with a new antifibrotic agent, pirfenidone. Am J Respir Crit Care Med 1999; 159:1061-9
  11. Behr J, Maier K, Krombach F, et al. Pathogenetic significance of reactive oxygen species in diffuse fibrosing alveolitis. Am Rev Respir Dis 1991; 144: 146-50
  12. Cantin AM, Hubbard RC, Crystal RG. Glutathione deficiency in the epithelial lining fluid of the lower respiratory tract in idiopathic pulmonary fibrosis. Am Rev Respir Dis 1989; 139: 370-2
  13. Behr J, Maier K, Degenkolb B, et al. Antioxidative and clinical effects of high-dose N-acetylcystein in fibrosing alveolitis. Am J Respir Crit Care Med 1997; 156:1897-901
  14. Tobin RW, Pope CE, Pellegrini CA, et al. Increased prevalence of gastrooesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care & Med 1998; 158: 1804-8
  15. Eklund A, Grünewald J. Sarcoidosis. In: Olivieri D, du Bois RM (eds). Intestitial Lung Diseases. Eur Respir Mon 2000; 14:96-119
  16. Westal